Advertisement

Topics

FDA approves Merck's Prevymis for post-stem cell transplant infections

05:20 EST 10 Nov 2017 | SmartBrief

Prevymis, or letermovir, Merck & Co.'s drug being developed for the prevention of cytomegalovirus infections in patients who  -More

Original Article: FDA approves Merck's Prevymis for post-stem cell transplant infections

NEXT ARTICLE

More From BioPortfolio on "FDA approves Merck's Prevymis for post-stem cell transplant infections"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...